Jafron Biomedical Co Ltd (300529)

Currency in CNY
23.78
+0.17(+0.72%)
Closed·
300529 Scorecard
Full Analysis
Has a perfect Piotroski Score of 9
300529 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
23.2223.81
52 wk Range
20.7339.24
Key Statistics
Bid/Ask
23.78 / 23.78
Prev. Close
23.61
Open
23.56
Day's Range
23.22-23.81
52 wk Range
20.73-39.24
Volume
7.77M
Average Volume (3m)
7.54M
1-Year Change
-12.68%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
300529 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
29.11
Upside
+22.39%
Members' Sentiments
Bearish
Bullish
ProTips
Management has been aggressively buying back shares

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Buy
Moving Averages
Strong Buy

Jafron Biomedical Co Ltd Company Profile

Jafron Biomedical Co.,Ltd. engages in the research, development, production, and sales of blood purification products for hemadsorption field in worldwide. The company provides solutions for ESRD diseases, acute poisoning, critical illness, hepatopathy, immunological disorders, kidney, and liver diseases. It offers HA series hemoperfusion cartridge, BS series bilirubin adsorption column and DNA immunoadsorption column, hemoperfusion machine, and blood purification machine; and other products, such as hemodialyzer, disinfectants, hemodialysis concentrate, resin bandages, online hemodialysis powder bag/bucket, and adsorbable suture with needles, as well as syringe and infusion pumps. The company was founded in 1989 and is based in Zhuhai, China.

Employees
2797
Market
China

Compare 300529 to Peers and Sector

Metrics to compare
300529
Peers
Sector
Relationship
P/E Ratio
25.2x26.6x−0.5x
PEG Ratio
0.620.440.00
Price/Book
5.2x2.1x2.6x
Price / LTM Sales
7.4x7.2x3.3x
Upside (Analyst Target)
23.3%27.1%45.1%
Fair Value Upside
Unlock14.9%7.4%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 29.11
(+22.39% Upside)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 0.93%
Dividend Yield
3.36%
Industry Median 1.85%
Annualised payout
0.80
Paid annually
5-Years Growth
+11.05%
Growth Streak

Earnings

Latest Release
Apr 15, 2025
EPS / Forecast
0.23 / --
Revenue / Forecast
547.84M / --
EPS Revisions
Last 90 days

300529 Income Statement

FAQ

What Stock Exchange Does Jafron Biomedical Trade On?

Jafron Biomedical is listed and trades on the Shenzhen Stock Exchange stock exchange.

What Is the Stock Symbol for Jafron Biomedical?

The stock symbol for Jafron Biomedical is "300529."

What Is the Jafron Biomedical Market Cap?

As of today, Jafron Biomedical market cap is 18.41B.

What Is Jafron Biomedical's Earnings Per Share (TTM)?

The Jafron Biomedical EPS (TTM) is 0.93.

When Is the Next Jafron Biomedical Earnings Date?

Jafron Biomedical will release its next earnings report on 21 Oct 2025.

From a Technical Analysis Perspective, Is 300529 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Jafron Biomedical Stock Split?

Jafron Biomedical has split 1 times.

How Many Employees Does Jafron Biomedical Have?

Jafron Biomedical has 2797 employees.

What is the current trading status of Jafron Biomedical (300529)?

As of 04 Aug 2025, Jafron Biomedical (300529) is trading at a price of 23.78, with a previous close of 23.61. The stock has fluctuated within a day range of 23.22 to 23.81, while its 52-week range spans from 20.73 to 39.24.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.